✦ LIBER ✦

Biophenotypes and survival of BRCA1 and TP53 deleted breast cancer in young women

✍ Scribed by Patrizia Querzoli; Giuseppe Albonico; Maria Grazia di Iasio; Stefano Ferretti; Rosa Rinaldi; Anna Cariello; Massimo Pedriali; Maurizio Matteuzzi; Iva Maestri; Italo Nenci

Book ID: 110292901
Publisher: Springer US
Year: 2001
Tongue: English
Weight: 70 KB
Volume: 66
Category: Article
ISSN: 0167-6806
DOI: 10.1023/a:1010643515095

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sporadic breast cancer in young women: P

Sporadic breast cancer in young women: Prevalence of loss of heterozygosity at p53, BRCA1 and BRCA2

✍ Suzanne M. Johnson; Jacqueline A. Shaw; Rosemary A. Walker 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 132 KB

## Abstract Previous studies have shown that breast cancers have more aggressive pathologic features in young women. In order to examine genetic alterations associated with early‐onset breast cancer, 31 patients with no known family history, aged 26–35 years at diagnosis, were examined for loss of

Breast cancer in young women: prevalence

Breast cancer in young women: prevalence of LOH atp53,BRCA1andBRCA2

✍ SM Johnson, JA Shaw, RA Walker 📂 Article 📅 2000 🏛 BioMed Central 🌐 English ⚖ 298 KB

Germline TP53 mutations in BRCA1 and BRC

Germline TP53 mutations in BRCA1 and BRCA2 mutation-negative French Canadian breast cancer families

✍ Suzanna L. Arcand; Christine M. Maugard; Parviz Ghadirian; André Robidoux; Chant 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 204 KB

BRCA1, BRCA2 and TP53 mutations among br

BRCA1, BRCA2 and TP53 mutations among breast cancer families from upper silesia in Poland

✍ H. Zientek; A. Jasinska; M. Rusin; P. Kozlowski; A. Sikorska; E. Kwiatkowska; E. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 357 KB

Allelic loss at BRCA1, BRCA2, and adjace

Allelic loss at BRCA1, BRCA2, and adjacent loci in relation to TP53 abnormality in breast cancer

✍ Su-Ling Tseng; Jyh-Cherng Yu; Chung-Tai Yue; Shu-Fen Chang; Tzu-Ming Chang; Chen 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB 👁 2 views

Cells with abnormal TP53 lose cell cycle checkpoints, resulting in genomic instability and neoplastic transformation. However, the evidence linking the tumor-specific targets of genomic alteration to an abnormal TP53 is limited. The present study tested the hypothesis that TP53 abnormalities are cor

BRCA1, BRCA2 and TP53 mutations in very

BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relatives

✍ Fiona Lalloo; Jennifer Varley; Anthony Moran; David Ellis; Lindsay O’Dair; Paul 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 143 KB